Mitochondrial complex II deficiency: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Mitochondrial complex II deficiency''', also called '''CII deficiency''', is a rare mitochondrial disease. As of 2013, about thirty-six cases had been reported.<ref name="Sciacovelli">{{cite journal|doi=10.1146/annurev-cancerbio-030419-033612|doi-access=free|title=Metabolic Drivers in Hereditary Cancer Syndromes|year=2020|last1=Sciacovelli|first1=Marco|last2=Schmidt|first2=Christina|last3=Maher|first3=Eamonn R.|last4=Frezza|first4=Christian|journal=Annual Review of Cancer Biology|volume=4|pages=77–97}}</ref>
{{SI}}
 
{{Infobox medical condition
==Classification and symptoms==
| name            = Mitochondrial complex II deficiency
Mitochondrial complex II deficiency affects the body's [[mitochondria]]<ref name="GARD">{{cite web|url=https://rarediseases.info.nih.gov/diseases/5053/mitochondrial-complex-ii-deficiency| title=Mitochondrial complex II deficiency| website=Genetic and Rare Diseases Information Center| access-date=25 June 2020}}</ref> and can have a variety of presentations. In some cases, the brain, heart, liver, kidneys, and muscles are affected, while in other cases, only the heart and muscles are affected with adult onset.<ref name="OMIM">{{cite web|url=https://www.omim.org/entry/252011| title=MITOCHONDRIAL COMPLEX II DEFICIENCY| website=OMIM| access-date=25 June 2020}}</ref> Common symptoms include the [[Babinski sign]], muscle weakness, distal [[amyotrophy]] (muscle wasting of the limbs), [[developmental regression]] (loss of developmental milestones), and being easy to fatigue.<ref name="GARD"/>
| image          = [[File:SuccDeh.svg|250px]]
 
| caption        = Diagram of succinate dehydrogenase, a key component of complex II
==Causes==
| synonyms        = Succinate dehydrogenase deficiency
CII deficiency is a genetic disorder with [[autosomal]] recessive inheritance,<ref name="OMIM"/> meaning that a person must inherit a genetic mutation from each parent to be affected.<ref name="GARD"/>
| specialty      = [[Medical genetics]]
 
| symptoms        = [[Muscle weakness]], [[hypotonia]], [[encephalopathy]], [[cardiomyopathy]], [[seizures]]
==Diagnosis==
| onset          = [[Infancy]] or [[childhood]]
The most effective way to diagnose CII deficiency is by measuring the activity of [[complex II]] in the muscles.<ref name="OMIM"/>
| duration        = [[Chronic]]
 
| causes          = Mutations in [[SDHA]], [[SDHB]], [[SDHC]], [[SDHD]] genes
==Prognosis==
| risks          = [[Genetic predisposition]]
In more severe cases where multiple organ systems are affected, death can occur in early life due to multisystem failure.<ref name="Sciacovelli"/>
| diagnosis      = [[Genetic testing]], [[muscle biopsy]], [[metabolic testing]]
 
| differential    = [[Leigh syndrome]], [[Mitochondrial complex I deficiency]]
==References==
| treatment      = [[Supportive care]], [[vitamin supplementation]]
{{reflist}}
| prognosis      = Variable, depending on severity
 
| frequency      = Rare
[[Category:Rare diseases]]
}}
[[Category:Genetic diseases and disorders]]
{{Short description|Overview of Mitochondrial Complex II Deficiency}}
'''Mitochondrial Complex II Deficiency''' is a rare [[metabolic disorder]] that affects the function of [[mitochondria]], the energy-producing structures within cells. This condition is characterized by a deficiency in the activity of [[Complex II]], also known as succinate dehydrogenase (SDH), which is part of the [[electron transport chain]] in mitochondria.
=== Pathophysiology ===
Complex II is unique among the complexes of the electron transport chain because it is the only one that participates in both the [[citric acid cycle]] and the electron transport chain. It catalyzes the oxidation of [[succinate]] to [[fumarate]] and transfers electrons to [[ubiquinone]]. A deficiency in Complex II disrupts this process, leading to impaired energy production and an accumulation of metabolic intermediates.
=== Clinical Presentation ===
Patients with mitochondrial complex II deficiency may present with a variety of symptoms, which can include [[muscle weakness]], [[hypotonia]], [[developmental delay]], and [[failure to thrive]]. The severity and range of symptoms can vary widely among affected individuals.
=== Genetic Basis ===
Mitochondrial complex II deficiency is often caused by mutations in one of the four nuclear genes that encode the subunits of succinate dehydrogenase: SDHA, SDHB, SDHC, and SDHD. These mutations can be inherited in an [[autosomal recessive]] manner.
=== Diagnosis ===
Diagnosis of mitochondrial complex II deficiency typically involves a combination of clinical evaluation, biochemical testing, and genetic analysis. Biochemical tests may show reduced activity of succinate dehydrogenase in muscle or liver tissue samples.
=== Treatment ===
Currently, there is no cure for mitochondrial complex II deficiency. Treatment is primarily supportive and may include nutritional supplements, physical therapy, and management of symptoms. Research into potential therapies is ongoing.
== See Also ==
* [[Mitochondrial disease]]
* [[Electron transport chain]]
* [[Succinate dehydrogenase]]
* [[Metabolic disorder]]
[[Category:Mitochondrial diseases]]
[[Category:Mitochondrial diseases]]
[[Category:Autosomal recessive disorders]]
[[Category:Metabolic disorders]]
{{dictionary-stub1}}

Latest revision as of 07:06, 6 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Mitochondrial complex II deficiency
Synonyms Succinate dehydrogenase deficiency
Pronounce N/A
Specialty Medical genetics
Symptoms Muscle weakness, hypotonia, encephalopathy, cardiomyopathy, seizures
Complications N/A
Onset Infancy or childhood
Duration Chronic
Types N/A
Causes Mutations in SDHA, SDHB, SDHC, SDHD genes
Risks Genetic predisposition
Diagnosis Genetic testing, muscle biopsy, metabolic testing
Differential diagnosis Leigh syndrome, Mitochondrial complex I deficiency
Prevention N/A
Treatment Supportive care, vitamin supplementation
Medication N/A
Prognosis Variable, depending on severity
Frequency Rare
Deaths N/A


Overview of Mitochondrial Complex II Deficiency


Mitochondrial Complex II Deficiency is a rare metabolic disorder that affects the function of mitochondria, the energy-producing structures within cells. This condition is characterized by a deficiency in the activity of Complex II, also known as succinate dehydrogenase (SDH), which is part of the electron transport chain in mitochondria.

Pathophysiology[edit]

Complex II is unique among the complexes of the electron transport chain because it is the only one that participates in both the citric acid cycle and the electron transport chain. It catalyzes the oxidation of succinate to fumarate and transfers electrons to ubiquinone. A deficiency in Complex II disrupts this process, leading to impaired energy production and an accumulation of metabolic intermediates.

Clinical Presentation[edit]

Patients with mitochondrial complex II deficiency may present with a variety of symptoms, which can include muscle weakness, hypotonia, developmental delay, and failure to thrive. The severity and range of symptoms can vary widely among affected individuals.

Genetic Basis[edit]

Mitochondrial complex II deficiency is often caused by mutations in one of the four nuclear genes that encode the subunits of succinate dehydrogenase: SDHA, SDHB, SDHC, and SDHD. These mutations can be inherited in an autosomal recessive manner.

Diagnosis[edit]

Diagnosis of mitochondrial complex II deficiency typically involves a combination of clinical evaluation, biochemical testing, and genetic analysis. Biochemical tests may show reduced activity of succinate dehydrogenase in muscle or liver tissue samples.

Treatment[edit]

Currently, there is no cure for mitochondrial complex II deficiency. Treatment is primarily supportive and may include nutritional supplements, physical therapy, and management of symptoms. Research into potential therapies is ongoing.

See Also[edit]